# ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defects in a Phase Ⅱ Clinical Trial

> **NCT06213727** · PHASE2 · COMPLETED · sponsor: **Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.** · enrollment: 180 (actual)

## Conditions studied

- Corneal Epithelial Defect

## Interventions

- **DRUG:** lowe-dose ZKY001 eye drops
- **DRUG:** Medium-dose ZKY001 eye drops
- **DRUG:** ZKY001 simulated eye drops

## Key facts

- **NCT ID:** NCT06213727
- **Lead sponsor:** Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-15
- **Primary completion:** 2022-11-14
- **Final completion:** 2022-11-14
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2024-01-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06213727

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06213727, "ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defects in a Phase Ⅱ Clinical Trial". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06213727. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*